WorldCare Clinical

What WorldCare Clinical does

WorldCare Clinical, operating as Voiant Clinical, is a global imaging contract research organization (CRO) founded in 1992 and headquartered in Cincinnati, Ohio. The company provides centralized imaging services for clinical trials conducted by pharmaceutical and biotechnology sponsors, with focus areas in oncology, ophthalmology, respiratory disease, and cardiovascular indications. Its offering combines subspecialty-trained clinical readers performing blinded independent central review (BICR) under protocols such as RECIST and RANO with a marketed purpose-built AI imaging platform and proprietary features including SILO Anatomy and AI-advanced OCT analysis (fluid segmentation, retinal layer tracking) and CT quantification with breath-hold standardization.

The company reports cumulative scale of 350+ oncology trials, 200+ ophthalmology studies, 125+ respiratory trials, and 45+ drug approvals supported, with a network of 2,700+ global imaging sites. It operates an enterprise sales model directed at pharma/biotech sponsors, with global offices in the US (New York, San Francisco, Los Angeles, Waltham, Austin), Germany (Munich), India (Hyderabad), and China (Shanghai), and Austin functions as an AI and imaging sciences engineering hub. Revenue is generated through professional-services pricing on a study-by-study basis rather than disclosed list pricing.

Adjacent capability is delivered through a strategic technology partnership with Voxeleron, whose AI-powered ophthalmology imaging is integrated into the company's trial services, particularly gene therapy trials in retinal disease. Leadership includes a Chief Scientific Officer, Senior VP of Artificial Intelligence, Senior VP of Imaging and Data Sciences, Medical Director, VP of Innovation, and VP of Quality Assurance and Regulatory. Ownership, funding history, and direct revenue disclosure are absent from the input data.

Name

WorldCare Clinical

Legal name

Voiant

Website

https://wcclinical.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

WorldCare Clinical, operating as Voiant Clinical, is a global clinical trial imaging CRO that combines a purpose-built AI platform with subspecialty-trained readers to deliver BICR, centralized imaging review, and endpoint data for pharmaceutical and biotechnology sponsors in oncology, ophthalmology, respiratory, and cardiovascular trials.

Ownership category

akta.pro rank

Product category

Clinical Trial Imaging CRO Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial imaging
• Imaging core lab
• Oncology imaging CRO
• Ophthalmic imaging services
• Centralized imaging review

Headquarters

HQ city

Cincinnati

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Imaging Services: Core CRO services for clinical trial imaging including centralized review, adjudication, and endpoint data management for pharmaceutical and biotechnology companies conducting clinical trials across oncology, ophthalmology, and respiratory therapeutic areas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

WorldCare Clinical (doing business as Voiant Clinical) is a global clinical trial imaging CRO that delivers centralized imaging review, blinded independent central review (BICR), adjudication, and image management for pharmaceutical and biotechnology sponsors. The company combines a proprietary AI-powered imaging platform with subspecialty-trained clinical readers to generate high-quality imaging endpoint data across oncology, ophthalmology, respiratory, and cardiovascular therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Clinical Trial Imaging Services End-to-end imaging core lab services for oncology clinical trials including blinded independent central review (BICR), RECIST and RANO assessments, and AI-powered imaging endpoint data delivery to pharmaceutical and biotechnology sponsors from early to late phase studies.
• Ophthalmology Reading Center Services Ophthalmic imaging and ocular safety trial services delivered by in-house certified readers, including advanced OCT analysis, fluid segmentation, and retinal layer tracking for pharmaceutical and biotechnology sponsors running ophthalmology clinical trials.
• Respiratory Clinical Trial Imaging Services Imaging core lab services for respiratory and pulmonary clinical trials, including expert reader evaluation, advanced CT quantification, airway and vascular analysis, and rigorous breath-hold standardization for consistent imaging endpoints across sites.
• Cardiovascular Clinical Trial Imaging Services Imaging core lab services for cardiovascular clinical trials, extending WorldCare Clinical / Voiant Clinical's centralized imaging review capabilities to cardiovascular therapeutic studies for pharmaceutical and biotechnology sponsors.

Quantifiable outcome

• 45+ drug approvals supported through clinical trial imaging services
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• VoxeleroncoreTechnology or IntegrationVoxeleron's AI-powered imaging technology is integrated into Voiant's clinical trial imaging services. Voiant leverages Voxeleron's AI capabilities to deliver faster analysis and deeper insights for gene therapy trials, particularly in ophthalmology (retinal diseases), raising the bar for imaging quality and speed in clinical trials.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: ICON plc is a top-3 global CRO with imaging services capabilities acquired through PRA Health Sciences and other deals. It competes with Voiant for multi-service trial contracts and has invested significantly in decentralized trial and imaging technologies.
• IQVIA: IQVIA is the world's largest CRO with comprehensive clinical trial services including imaging core lab capabilities. While not specialized in imaging, IQVIA competes for full-service trial contracts where imaging is bundled with broader CRO offerings.
• Medpace: Medpace is a mid-to-large CRO with significant therapeutic expertise in oncology and other areas. While not a dedicated imaging CRO, it integrates imaging core lab services into its full-service trial offerings for biotech sponsors.
• Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a major CRO offering central laboratory and imaging services for clinical trials. Its broad diagnostic capabilities and global infrastructure make it a competitor for imaging-enabled trial programs.

Direct peers

• Imaging Endpoints: Imaging Endpoints is one of the largest independent imaging CROs, providing BICR and central image review for oncology trials with a similar focus on subspecialty-trained radiologists. It competes head-to-head with Voiant in oncology imaging core lab services.
• Clario (formerly BioClinica): Clario (formed from the merger of BioClinica and ERT) is a direct competitor offering clinical trial imaging core lab services including BICR, alongside eCOA and endpoint solutions. It serves the same pharma/biotech sponsor base for oncology, ophthalmology, and respiratory trials with a comparable global footprint.
• Median Technologies: Median Technologies provides AI-based imaging CRO services and imaging phenotyping for oncology clinical trials, directly competing with Voiant's iBICR/central review offerings. Both companies emphasize AI-driven image analysis to accelerate trial endpoints.
• Invicro (Perceptive): Invicro, now part of Perceptive Life Sciences, provides imaging CRO services for clinical trials with a particular focus on neurology, oncology, and ophthalmology. It directly competes with Voiant in central imaging review and advanced image quantification.
• Bioclinica (legacy entity) / ERT: Now operating as Clario, the legacy Bioclinica imaging core lab and ERT imaging businesses were both direct competitors to Voiant in BICR and central imaging for clinical trials. They serve the same sponsor base with overlapping oncology and ophthalmology trial capabilities.

Emerging players

• Calyx (formerly PAREXEL imaging): Calyx provides imaging management and clinical trial technology solutions, including AI-enabled medical image review. As a technology-focused CRO-adjacent vendor, it overlaps with Voiant's imaging core lab value proposition in select therapeutic areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/worldcare-clinical-llc
• Xx.com/worldcareclinic

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WorldCare Clinical